New Section Editor for Pulmonary Perspectives®

We are pleased to announce Corey Kershaw, MD, as the new Section Editor for Pulmonary Perspectives. Dr. Kershaw is the Medical Director of the Medical Intensive Care Unit at Clements University Hospital and an Associate Professor, Division of Pulmonary and Critical Care Medicine, University of Texas Southwestern Medical Center, in Dallas, Texas. He currently serves on the American College of Chest Physicians Interstitial and Diffuse Lung Disease NetWork. Dr. Kershaw’s research interests revolve around clinical trials for the treatment of idiopathic pulmonary fibrosis and other fibrosing interstitial lung diseases.

We thank Nitin Puri, MD, FCCP, for his outstanding service as the Pulmonary Perspectives Section Editor for the previous 3 years. 

We are pleased to announce Corey Kershaw, MD, as the new Section Editor for Pulmonary Perspectives. Dr. Kershaw is the Medical Director of the Medical Intensive Care Unit at Clements University Hospital and an Associate Professor, Division of Pulmonary and Critical Care Medicine, University of Texas Southwestern Medical Center, in Dallas, Texas. He currently serves on the American College of Chest Physicians Interstitial and Diffuse Lung Disease NetWork. Dr. Kershaw’s research interests revolve around clinical trials for the treatment of idiopathic pulmonary fibrosis and other fibrosing interstitial lung diseases.

We thank Nitin Puri, MD, FCCP, for his outstanding service as the Pulmonary Perspectives Section Editor for the previous 3 years. 

We are pleased to announce Corey Kershaw, MD, as the new Section Editor for Pulmonary Perspectives. Dr. Kershaw is the Medical Director of the Medical Intensive Care Unit at Clements University Hospital and an Associate Professor, Division of Pulmonary and Critical Care Medicine, University of Texas Southwestern Medical Center, in Dallas, Texas. He currently serves on the American College of Chest Physicians Interstitial and Diffuse Lung Disease NetWork. Dr. Kershaw’s research interests revolve around clinical trials for the treatment of idiopathic pulmonary fibrosis and other fibrosing interstitial lung diseases.

We thank Nitin Puri, MD, FCCP, for his outstanding service as the Pulmonary Perspectives Section Editor for the previous 3 years.